Company / Total Assets
Oruka Therapeutics, Inc. Total Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.0K
FY2024
5-year range
$1.0K / $54.9M
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
#214 of 214
Health Care
What the data says
Among 214 Health Care companies, Oruka Therapeutics, Inc. is in the bottom 0% for total assets. Total Assets has declined for 3 consecutive years, from $55M in FY2021 to $1,000 in FY2024.
Based on SEC 10-K filings.
$1,000 in FY2024 with a 5-year CAGR of -83.6%.
Declined from $43M to $1,000 over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -97.4%
- 5-Year CAGR
- -83.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 214This company $1.0K Sector average $7.5B
▼
-100.0% below sector average
Key checks
Key Insights
- Oruka Therapeutics, Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of -83.6%, indicating a declining trend.
- In FY2024, total assets decreased 100.0% year-over-year.
- Ranks #214 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.0K | -100.0% |
| FY2023 | $37.9M | -12.1% |
| FY2022 | $43.1M | -21.6% |
| FY2021 | $54.9M | +8.9% |
| FY2020 | $50.4M | +490.8% |
| FY2019 | $8.5M | +25.1% |
| FY2018 | $6.8M | -44.8% |
| FY2017 | $12.4M | -49.8% |
| FY2016 | $24.6M | -37.8% |
| FY2015 | $39.6M | +145.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026